Transforming growth factor Beta1 / Smad signalling pathway of aortic disorders: histopathological and immunohistochemical studies

• Autorzy: Yuan S-M
• Języki publikacji: EN

Abstrakty

EN

Background: The aim of the present study was to evaluate the expressions and biological functions of the TGF-β₁/Smad signalling pathway of aortic disorders by way of histopathological and immunohistochemical studies. Material and methods: Aortic specimens of 20 patients with aortic dissection, 9 patients with aortic aneurysm, 9 patients with coronary artery disease, and 5 deceased healthy adults were collected. The samples were stained with haematoxylin-eosin, Masson’s trichrome, van Gieson, and alcian blue, and with immunohistochemical stainings to detect TGF-β₁, type I receptor (TβRI), Smad2/3, Smad4, and Smad7. Results: Masson’s trichrome and van Gieson stainings showed attenuated collagens in the aorta of the patients with aortic dissection and aortic aneurysm. TGF-β₁, TβRI, and Smad2/3 mainly showed a cytoplasmic immunoreactivity in the aor-tic media, Smad4 immunoreactivity was predominantly located in the cytoplasm and/or the nucleus of the aortic media, and Smad7 immunoreactivity was present in the nucleus of the aortic media and intima. The TGF-β₁ signalling pathway proteins were similarly expressed in the aorta of aortic dissection and aortic aneurysm patients, while they were less pronounced in the aorta of coronary artery disease patients, and weak or negative in the aorta of healthy control individuals. Conclusions: These observations support the notion that there is an association between the TGF-β₁/Smad pathway and the pathological events of the aorta. Dysregulation of the TGF-β₁/Smad pathway may predispose the pathologenesis of aortic disorders. (Folia Morphol 2012; 71, 1: 31–38)

• Wydawca: -
• Czasopismo: Folia Morphologica
• Rocznik: 2012
• Tom: 71
• Numer: 1
• Opis fizyczny: p.31-38,fig.,ref.

Twórcy

autor

Yuan S-M

• Department of Cardiothoracic Surgery, Affiliated Hospital of Taishan Medical College, Shandong Province, People’s Republic of China, 706 Taishan Street, Taishan District, Taian 271000

Bibliografia

• 1. Agrotis A, Kalinina N, Bobik A (2005) Transforming growth factor-beta, cell signaling and cardiovascular disorders. Curr Vasc Pharmacol, 3: 55–61.
• 2. Chowdhury UK, Mishra AK, Ray R, Kalaivani M, Reddy SM, Venugopal P (2008) Histopathologic changes in ascending aorta and risk factors related to histopathologic conditions and aortic dilatation in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg, 135: 69–77,77.e1-11.
• 3. Costello I, Biondi CA, Taylor JM, Bikoff EK, Robertson EJ (2009) Smad4-dependent pathways control basement membrane deposition and endodermal cell migration at early stages of mouse development. BMC Dev Biol, 9: 54.
• 4. Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, Murphy-Ullrich JE, Hugo C (2004) Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int, 65: 459–468.
• 5. de Sa M, Moshkovitz Y, Butany J, David TE (1999) Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the ross procedure. J Thorac Cardiovasc Surg, 118: 588–594.
• 6. Dietz HC (2010) TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. J Clin Invest, 120: 403–407.
• 7. Flanders KC (2004) Smad3 as a mediator of the fibrotic response. Int J Exp Pathol, 85: 47–64.
• 8. Frutkin AD, Otsuka G, Stempien-Otero A, Sesti C, Du L, Jaffe M, Dichek HL, Pennington CJ, Edwards DR, Nieves-Cintrón M, Minter D, Preusch M, Hu JH, Marie JC, Dichek DA (2009) TGF-beta1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol, 29: 1251–1257.
• 9. Fukui D, Miyagawa S, Soeda J, Tanaka K, Urayama H, Kawasaki S (2003) Overexpression of transforming growth factor beta1 in smooth muscle cells of human abdominal aortic aneurysm. Eur J Vasc Endovasc Surg, 25: 540–545.
• 10. Gomez D, Al Haj Zen A, Borges LF, Philippe M, Gutierrez PS, Jondeau G, Michel JB, Vranckx R (2009) Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol, 218: 131–142.
• 11. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM (1993) Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science, 260: 1655–1658.
• 12. Grond-Ginsbach C, Pjontek R, Aksay SS, Hyhlik-Dürr A, Böckler D, Gross-Weissmann ML (2010) Spontaneous arterial dissection: phenotype and molecular pathogenesis. Cell Mol Life Sci, 67: 1799–1815.
• 13. Gutierrez PS, de Almeida IC, Nader HB, Higuchi ML, Stolf N, Dietrich CP (1991) Decrease in sulphated glycosaminoglycans in aortic dissection: possible role in the pathogenesis. Cardiovasc Res, 25: 742–748.
• 14. Iwano M (2010) EMT and TGF-beta in renal fibrosis. Front Biosci (Schol Ed), 2: 229–238.
• 15. Karthikeyan M, Blobe GC (2007) TGF-beta type I receptor. UCSD-Nature Molecule Pages, doi:10.1038/mp.a002272.01.
• 16. Kubo M, Ihn H, Yamane K, Tamaki K (2006) The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans. Br J Dermatol, 154: 919–925.
• 17. Matthias Bechtel JF, Noack F, Sayk F, Erasmi AW, Bartels C, Sievers HH (2003) Histopathological grading of ascending aortic aneurysm: comparison of patients with bicuspid versus tricuspid aortic valve. J Heart Valve Dis, 12: 54–59.
• 18. Miyazono K (2000) TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev, 11: 15–22.
• 19. Nakagawa T, Sukhova GK, Rabkin E, Winters GL, Schoen FJ, Libby P (1995) Acute rejection accelerates graft coronary disease in transplanted rabbit hearts. Circulation, 92: 987–993.
• 20. Natsugoe S, Xiangming C, Matsumoto M, Okumura H, Nakashima S, Sakita H, Ishigami S, Baba M, Takao S, Aikou T (2002) Smad4 and transforming growth factor b1 expression in patients with squamous cell carcinoma of the esophagus. Clin Cancer Res, 8: 1838–1842.
• 21. Park JH, Youn HJ, Yoon JS, Park CS, Oh SS, Chung WB, Chung JW, Choi YS, Lee DH, Oh YS, Chung WS, Hong SJ, Lee YS, Sim SB, Lee SH (2009) The expression of transforming growth factor-β₁ and α-smooth muscle actin is increased in the human myxomatous valve. Korean J Pathol, 43: 152–156.
• 22. Recchia D, Sharkey AM, Bosner MS, Kouchoukos NT, Wickline SA (1995) Sensitive detection of abnormal aortic architecture in Marfansyndrome with high-frequency ultrasonic tissue characterization. Circulation, 91: 1036–1043.
• 23. Rodríguez-Vita J, Sánchez-López E, Esteban V, Rupérez M, Egido J, Ruiz-Ortega M (2005) Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factorbeta-independent mechanism. Circulation, 111: 2509–2517.
• 24. Sangiorgi G, Trimarchi S, Mauriello A, Righini P, Bossone E, Suzuki T, Rampoldi V, Eagle KA (2006) Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection. J Cardiovasc Med (Hagerstown), 7: 307–715.
• 25. Shi Y, Massagué J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 113: 685–700.
• 26. Yang SG, Wang CS, Chen H, Hong T, Lai H, Zhu SJ (2008) Comparison of TGF-beta1 distribution and expression in aortic wall of thoracic aortic dissection versus aneurysm. J Fudan Uni (Med Sci), 35: 681–686.